A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer

Author(s):  Kramer Mark A, Grilley Bambi J

Issue:  Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Page(s):  271-273

Related Articles from IJPC
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Kramer Mark A, Grilley Bambi J	Jul/Aug 2002 Pg. 271-273
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A	Sep/Oct 2009 Pg. 400-403
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Disposing of Expired Drugs and Chemicals: New Options for Compounders Vail Jane	Jan/Feb 2008 Pg. 38-47 View Sample
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
PreScription: New Drug Approvals 2022 and Compounding Opportunities Allen Loyd V Jr	Jan/Feb 2023 Pg. 4
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Allen Loyd V Jr	Sep/Oct 2007 Pg. 438-439
Compounding OTC Drugs: A Legal Perspective Gibbs Jeffrey N, Mazan Kate Duffy	May/Jun 2000 Pg. 180-181
Return to Top